Woundbiotech: Uncommon Wounds

Dr. Falanga
8/7/00		 Return to Woundbiotech

Return to Wounds: Common and Uncommon

01. 02. 03a. 03b. 04. 05.
1. Rheumatoid leg ulcer 2. Rheumatoid leg ulcer 3b. Pyoderma gangrenosum after treatment 4. Early pyoderma gangrenosum 5. Pyoderma gangrenosum
06. 07a. 07b. 08. 09. 10a.
6. Pyoderma gangrenosum 7a. Atypical pyoderma gangrenosum 7b. Relapsing polychondritis 8. Pyoderma gangrenosum of the ankle 9. Pyoderma gangrenosum of the foot 10a. Pyoderma gangrenosum and arthritis
10b. 11a. 11b. 11c. 11d. 11e.
10b. Pyoderma gangrenosum and arthritis 11a. Pyoderma gangrenosum in a young woman 11b. Pyoderma gangrenosum in a young woman 11c. Pyoderma gangrenosum in a young woman 11d. Pyoderma gangrenosum in a young woman 11e. Pyoderma gangrenosum in a young woman
12a. 12b. 12c. 13. 14. 15a.
12a. Lichen planus of the foot 12b. Lichen planus of the foot 12c. Lichen planus of the foot 13. Angular ulcers in collagen vascular disease 14. Angular ulcers in localized scleroderma 15a. Short contact tretinoin therapy
15b. 15c. 16. 17. 18a. 18b.
15b. Short contact tretinoin therapy 15c. Short contact tretinoin therapy 16. Scleroderma ulcer 17. Scleroderma ulcers 18a. Scleroderma ulcer and bioengineered skin 18b. Scleroderma ulcer and bioengineered skin
18c. 18d. 19. 20. 21a. 21b.
18c. Scleroderma ulcer and bioenginereed skin 18d. Scleroderma ulcer and bioengineered skin 19. Acute lipodermatosclerosis 20. Leukocytoclastic vasculitis 21a. Severe leukocytoclastic vasculitis 21b. Severe leukocytoclastic vasculitis
22a. 22b. 23a. 23b 24. 25.
22a. Leukocytoclastic vasculitis with systemic involvement 22b. Leukocytoclastic vasculitis with systemic involvement 23a. Polyarteritis nodosa Polyarteritis nodosa/Healed ulcer 24. Livedo reticularis 25. Microlivedo
26a. 26b. 27. 28a. 28b. 29a.
26a. Antiphospholipid syndrome 26b. Antiphospholipid syndrome 27. Calciphylaxis 28a. Cholesterol embolization 28b. Cholesterol embolization 29a. Ulcer from cryofibrinogenemia
29b. 30a. 30b. 31a. 31b. 32a
29b. Ulcer from cryofibrinogenemia 30a. Ulcers from cryofibrinogenemia 30b. Ulcers from cryofibrinogenemia 31a. Microlivedo and cryofibrinogenemia 31b. Microlivedo and cryofibrinogenemia 32a. Vasculitis vs. cryofibrinogenemic ulcers
32b. 33a. 33b. 34.
32b. Vasculitis vs. cryofibrinogenemic ulcers 33a. Cryoglobulinemia and ulcers 33b. Cryoglobulinemia and ulcers 34. Pain from cryoglobulinemia
10 May 2000
Department of Dermatology
School of Medicine
Boston University